Ottawa, Canada

Risini Dhammika Weeratna

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Risini Dhammika Weeratna: Innovator in Adjuvant Compositions

Introduction

Risini Dhammika Weeratna is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of immunology through her innovative work on adjuvant compositions. With a total of 8 patents to her name, Weeratna's inventions are paving the way for advancements in vaccine development and animal treatment.

Latest Patents

Weeratna's latest patents focus on adjuvant formulations that comprise various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators. These inventions detail methods for creating the adjuvant compositions and their applications in immunogenic and vaccine compositions with different antigens. Furthermore, her work extends to the use of these formulations in the treatment of animals, showcasing her commitment to improving health outcomes in both humans and animals.

Career Highlights

Throughout her career, Weeratna has worked with notable companies such as Zoetis Services LLC and Zoetis LLC. Her experience in these organizations has allowed her to refine her expertise in the development of innovative adjuvant compositions.

Collaborations

Weeratna has collaborated with esteemed colleagues, including Paul Joseph Dominowski and Richard Lee Krebs. These partnerships have contributed to her success and the advancement of her research in immunology.

Conclusion

Risini Dhammika Weeratna is a trailblazer in the field of adjuvant compositions, with a strong portfolio of patents that reflect her innovative spirit. Her work continues to influence the development of vaccines and treatments, making a lasting impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…